S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Why Turkey's currency is crashing after Erdogan got reelected
Get Your Cash Out of U.S. Banks Immediately (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Why Turkey's currency is crashing after Erdogan got reelected
Get Your Cash Out of U.S. Banks Immediately (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Why Turkey's currency is crashing after Erdogan got reelected
Get Your Cash Out of U.S. Banks Immediately (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
3 Mid Caps You Haven't Heard Of But Need To Know About
Why Turkey's currency is crashing after Erdogan got reelected
Get Your Cash Out of U.S. Banks Immediately (Ad)
Even at $2,000+ Per Share, These 3 Stocks Are Deals
Will NIO Partake In China's Economic Awakening?
“One-Stock Millionaire” IGNORES 99.9% of the Market (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
NYSE:CLB

Core Laboratories (CLB) Stock Forecast, Price & News

$24.90
-1.30 (-4.96%)
(As of 06/9/2023 ET)
Compare
Today's Range
$24.80
$26.01
50-Day Range
$20.55
$26.20
52-Week Range
$13.19
$27.12
Volume
436,003 shs
Average Volume
378,362 shs
Market Capitalization
$1.16 billion
P/E Ratio
49.80
Dividend Yield
0.16%
Price Target
$22.30

Core Laboratories MarketRank™ Forecast

Analyst Rating
Reduce
1.33 Rating Score
Upside/​Downside
10.4% Downside
$22.30 Price Target
Short Interest
Healthy
8.37% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.39mentions of Core Laboratories in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
36.25%
From $0.80 to $1.09 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.17 out of 5 stars

Oils/Energy Sector

172nd out of 252 stocks

Oil & Gas Field Services, Not Elsewhere Classified Industry

14th out of 20 stocks


CLB stock logo

About Core Laboratories (NYSE:CLB) Stock

Core Laboratories, Inc. provides proprietary and patented reservoir description and production enhancement services. The company was founded on May 1, 2023 and is headquartered in Houston, TX.

Receive CLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

CLB Stock News Headlines

Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Core Laboratories (NYSE:CLB) Shares Up 6.1%
“You need at least $100 of this asset – and it’s NOT gold” – Dr. Nomi Prin
$100 is all you need… Former Goldman Sachs managing director Dr. Nomi Prins has identified an investment she’s calling ‘the world’s hardest asset’ – and she’s recommending it to friends, family, and followers.
The Latest Analyst Ratings for Core Laboratories
CORE LAB REPORTS FIRST QUARTER 2023 RESULTS:
Core Laboratories (CLB) to Release Earnings on Wednesday
Core Laboratories (NYSE:CLB) Shares Gap Down to $22.31
See More Headlines

CLB Price History

CLB Company Calendar

Last Earnings
4/26/2023
Ex-Dividend for 5/30 Dividend
5/05/2023
Dividend Payable
5/30/2023
Today
6/10/2023
Next Earnings (Estimated)
7/26/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Oil & gas field services, not elsewhere classified
Sub-Industry
N/A
Fax
N/A
Employees
3,600
Year Founded
1936

Price Target and Rating

Average Stock Price Forecast
$22.30
High Stock Price Forecast
$26.00
Low Stock Price Forecast
$19.00
Forecasted Upside/Downside
-10.4%
Consensus Rating
Reduce
Rating Score (0-4)
1.33
Research Coverage
3 Analysts

Profitability

Net Income
$19.45 million
Pretax Margin
7.17%

Debt

Sales & Book Value

Annual Sales
$489.73 million
Cash Flow
$0.91 per share
Book Value
$4.07 per share

Miscellaneous

Free Float
46,402,000
Market Cap
$1.16 billion
Optionable
Optionable
Beta
2.67

Social Links


Key Executives

  • Lawrence V. Bruno
    Chairman, President & Chief Executive Officer
  • Christopher S. Hill
    Chief Financial Officer & Senior Vice President
  • Mark Damian Tattoli
    Secretary, Senior Vice President & General Counsel
  • Kevin G. Daniels
    Chief Accounting Officer & Vice President
  • J. Donald Dumas
    SVP-Production Enhancement & Business Development













CLB Stock - Frequently Asked Questions

Should I buy or sell Core Laboratories stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 2 sell ratings and 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "sell" CLB shares.
View CLB analyst ratings
or view top-rated stocks.

What is Core Laboratories' stock price forecast for 2023?

3 equities research analysts have issued twelve-month target prices for Core Laboratories' stock. Their CLB share price forecasts range from $19.00 to $26.00. On average, they predict the company's share price to reach $22.30 in the next year. This suggests that the stock has a possible downside of 10.4%.
View analysts price targets for CLB
or view top-rated stocks among Wall Street analysts.

How have CLB shares performed in 2023?

Core Laboratories' stock was trading at $20.27 at the beginning of 2023. Since then, CLB shares have increased by 22.8% and is now trading at $24.90.
View the best growth stocks for 2023 here
.

Are investors shorting Core Laboratories?

Core Laboratories saw a decrease in short interest in May. As of May 15th, there was short interest totaling 3,860,000 shares, a decrease of 26.1% from the April 30th total of 5,220,000 shares. Based on an average daily trading volume, of 399,100 shares, the days-to-cover ratio is presently 9.7 days. Approximately 8.4% of the shares of the company are short sold.
View Core Laboratories' Short Interest
.

When is Core Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 26th 2023.
View our CLB earnings forecast
.

How were Core Laboratories' earnings last quarter?

Core Laboratories Inc. (NYSE:CLB) posted its earnings results on Wednesday, April, 26th. The oil and gas company reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.14 by $0.06. The oil and gas company had revenue of $128.36 million for the quarter, compared to analyst estimates of $126.26 million. Core Laboratories had a net margin of 4.72% and a trailing twelve-month return on equity of 15.23%.

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories declared a quarterly dividend on Wednesday, April 26th. Shareholders of record on Monday, May 8th will be paid a dividend of $0.01 per share on Tuesday, May 30th. This represents a $0.04 dividend on an annualized basis and a yield of 0.16%. The ex-dividend date is Friday, May 5th.
Read our dividend analysis for CLB
.

Is Core Laboratories a good dividend stock?

Core Laboratories (NYSE:CLB) pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.16%. The dividend payout ratio is 8.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CLB will have a dividend payout ratio of 3.67% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CLB.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories updated its second quarter 2023 earnings guidance on Thursday, April, 27th. The company provided earnings per share (EPS) guidance of $0.20-$0.24 for the period, compared to the consensus EPS estimate of $0.21. The company issued revenue guidance of $130.00 million-$135.00 million, compared to the consensus revenue estimate of $132.83 million.

What is David M. Demshur's approval rating as Core Laboratories' CEO?

60 employees have rated Core Laboratories Chief Executive Officer David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among the company's employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.33%), Boston Trust Walden Corp (4.49%), State Street Corp (2.74%), Ameriprise Financial Inc. (1.93%), Van ECK Associates Corp (1.83%) and Dimensional Fund Advisors LP (1.70%).
View institutional ownership trends
.

How do I buy shares of Core Laboratories?

Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $24.90.

How much money does Core Laboratories make?

Core Laboratories (NYSE:CLB) has a market capitalization of $1.16 billion and generates $489.73 million in revenue each year. The oil and gas company earns $19.45 million in net income (profit) each year or $0.50 on an earnings per share basis.

How many employees does Core Laboratories have?

The company employs 3,600 workers across the globe.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The official website for the company is www.corelab.com. The oil and gas company can be reached via phone at (713) 328-2673 or via email at investor.relations@corelab.com.

This page (NYSE:CLB) was last updated on 6/10/2023 by MarketBeat.com Staff

My Account -